These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6581751)

  • 1. [Daunomycin and atrial fibrillation].
    Fuster Siebert M; Fernández Iglesias A; Couselo Sánchez JM; Gallego García D; Iglesias Diz JL; Alvez González F
    An Esp Pediatr; 1983 Nov; 19(5):415-6. PubMed ID: 6581751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R
    Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute myeloid leukemia with daunomycin (38 cases)].
    D'auteuil P; Harel P
    Union Med Can; 1976 Feb; 105(2):205-10. PubMed ID: 1069395
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.
    van Eys J; Steuber P; Haggard ME; Sabio H; Duncan M
    Am J Pediatr Hematol Oncol; 1981; 3(3):301-3. PubMed ID: 7025685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myelogenous leukemia treated with daunomycin associated with nephrotic syndrome.
    Thomson M; de Arriba G; Ordi J; Oliva H; Hernando L
    Nephron; 1989; 51(2):261-4. PubMed ID: 2915765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute granulocytic leukemias with daunomycin].
    Eur J Cancer (1965); 1969 Sep; 5(4):339-42. PubMed ID: 5259625
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
    Jakl M; Horacek JM; Jebavy L; Pudil R
    Leuk Res; 2009 Aug; 33(8):e109-10. PubMed ID: 19237194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y; Bolduc P
    Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of daunomycin cardiotoxicity in a case of acute myelogeneous leukemia associated with Sweet's syndrome.
    Imamura N; Miura K; Kuramoto A
    Hiroshima J Med Sci; 1985 Jun; 34(2):253-6. PubMed ID: 3861598
    [No Abstract]   [Full Text] [Related]  

  • 11. Time relationship between last dose of daunorubicin and congestive heart failure.
    Von Hoff DD; Layard M; Rozencweig M; Muggia FM
    Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Left ventricular thrombosis in a case of daunomycin cardiomyopathy].
    De Santis F; Corbo S; Vigna C; Pennestrì F; Loperfido F
    Cardiologia; 1985 Feb; 30(2):139-41. PubMed ID: 2933147
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
    Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin].
    Marty M; Ganem G; Fischer J; Flandrin G; Berger R; Schaison G; Degos L; Boiron M
    Nouv Rev Fr Hematol (1978); 1984; 26(6):371-8. PubMed ID: 6597407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL; Bonnet-Gajdos M; Mougenot B
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the effect of cellular morphology on obtaining a complete remission in 99 cases of acute leukemia].
    Ríos A; Rozman C; Del Cañizo MC; Brugués R
    Sangre (Barc); 1984; 29(3):273-9. PubMed ID: 6592764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined treatment of acute leukemia with L-asparaginase and daunomycin].
    Gerhartz H
    Haematol Lat; 1969; 12(3):821-7. PubMed ID: 5273188
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac ultrastructural changes induced by daunorubicin therapy.
    Buja LM; Ferrans VJ; Mayer RJ; Roberts WC; Henderson ES
    Cancer; 1973 Oct; 32(4):771-88. PubMed ID: 4270890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
    Dano K; Nissen NI
    Nord Med; 1968 Oct; 80(44):1469-74. PubMed ID: 5247179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.